Manufacturing

share

Sanofi has signed a licence agreement to develop Principia Biopharma’s Bruton’s tyrosine kinase (BTK) inhibitor (PRN2246), which is...

4 shares

Recipharm has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines....

share

CordenPharma has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from...

share

Merck announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance viral and gene therapy products has completed...

share

MilliporeSigma today announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance...

share

Servier CDMO announces that the company has invested $7.5 million USD in intensified technology included continuous chromatography with simulated...

share

Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France. The expansion...

share

Bioverativ and Bicycle Therapeutics announced a research collaboration focused on the discovery, development and commercialization of innovative therapies for...